CEPI seeks its next Chief Executive Officer. The need for CEPI is greater now than ever before. Epidemic and pandemic threats are growing more complex and unpredictable. The world is increasingly fragmented — and more vulnerable — than it has been in decades. Yet, paradoxically, our capacity to respond has never been stronger. Science and technology now give us tools previous generations could only imagine. 

CEPI is working to take many of the most menacing epidemic and pandemic threats off the table by investing in preparedness, innovation and equity now to develop life-saving vaccines against known threats like Lassa fever and Nipah and to dramatically reduce the future risk of pandemics through the 100 Days Mission, making the world a safer place for all. Founded in 2017, the organization is a Coalition of vaccine developers, manufacturers, sovereign governments, philanthropies, civil society and global health organizations. It receives financial support from over 30 countries and philanthropies. 

Compelling candidates will be able to demonstrate their track record of success as a CEO or senior leader of a significant organization, and ability to navigate a highly complex, ambiguous world, with multiple stakeholders and partners. They will be familiar with vaccines, public health, and epidemic preparedness, and understand the global health architecture. Candidates should also be able to demonstrate success in leading a high-performance, healthy institution, with respect to financial management, people & culture, and the delivery of results. Finally, candidates should be compelling communicators in English, and experienced in working in a multicultural environment, with a deep respect for others, from all nations and all walks of life. 

Saxton Bampfylde Ltd is acting as an employment agency advisor to the CEPI on this appointment. For further information about the role, including details about how to apply, please visit roles.saxbam.com using reference NBYCA. Alternatively email Belinda.beck@saxbam.com. Applications should be received by midday UK time on Tuesday 5 May.